Eyal Lebel

15PUBLICATIONS
27CO-AUTHORS
Medical mycologyCancer therapy (excl. chemotherapy and radiation therapy)AutoimmunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Aug 13, 2026
Free Light Chain Monomer-Dimer Pattern Analysis as Non-Invasive Tool in Predicting MGUS and SMM Progression.

|Apr 14, 2026
Viral Reactivation in Multiple Myeloma Patients Receiving Anti-BCMA Chimeric Antigen Receptor T-Cell Therapy.

Ido Cohen, Eyal Lebel, Sigal Grisariu

|Nov 13, 2025
High Rate of Cytokine Release Syndrome-Related Coagulopathy with Low Incidence of Bleeding and Thrombosis in Patients Treated with B-Cell Maturation Antigen (BCMA)-Targeted Chimeric Antigen Receptor T-Cells (CAR-T).

Ariela Arad, Maya Katz, Eyal Lebel

|Oct 16, 2025
First case report of talquetamab use in AL amyloidosis.

Noa Gross Even-Zohar, Shlomzion Aumann, Adir Shaulov

|Dec 09, 2024
Efficacy and Safety of Anti-B-Cell Maturation Antigen Chimeric Antigen Receptor T-Cell for the Treatment of Relapsed and Refractory AL Amyloidosis.

Eyal Lebel, Nathalie Asherie, Shlomit Kfir-Erenfeld

|May 20, 2024
Clinical evaluation and determinants of response to HBI0101 (BCMA CART) therapy in relapsed/refractory multiple myeloma.

Shlomit Kfir-Erenfeld, Nathalie Asherie, Eyal Lebel

Pageof 3

Frequent Collaborators

8 joint publications

Moshe E Gatt

4 joint publications

Marjorie Pick

4 joint publications

Nathalie Asherie

4 joint publications

Batia Avni